Being Smart About Global Versus Local During Clinical Research Trials
as seen in the
The Monitor, a bimonthly publication of the Association of Clinical Research Professionals (ACRP)
by Inna Kassatkina, Donald A. DePalma, Mary Stober
vol. 21, issue 7, December 2007, pages 47-50
As drug development expands globally, today's pharmaceutical project managers need to master management techniques, tools, and measures that transcend language, cultural, and geopolitical barriers. Industry leaders like AstraZeneca and Pfizer need to employ new technologies that will allow their global team members to collaborate better and to manage critical information on local, international, and global levels.
Each stage of the drug's life cycle is touched by language, culture, and national infrastructure needs. Pharmaceutical and other life sciences companies selling their products internationally typically adapt the product itself and how it is offered—the language, website, marketing collateral, selling method, delivery mode, and support network used to sweeten the deal-to the needs of doctors and other consumers in their target markets.
The article, which is included as part of the December 2007 issue's Home Study test for continued education credits, offers several tips for successful globalization.
Request the full article.
